TALS Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-12-13 | SIEGALL CLAY B | director | 20,000 | A-Award | A | 20,000 | 18.55 | 371,000.00 |
2023-12-13 | SIEGALL CLAY B | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-11-17 | Kulkarni Sandeep Chidambar | director, officer: CEO | 729,735 | P-Purchase | A | 4,000 | 16.99 | 67,960.00 |
2023-11-17 | Thiara Parvinder | director | 83,782 | P-Purchase | A | 1,000 | 17.31 | 17,310.00 |
2023-10-27 | Castelein Caley | director | 516,519 | P-Purchase | A | 15,800 | 14.55 | 229,890.00 |
2023-10-25 | Castelein Caley | director | 500,719 | P-Purchase | A | 4,200 | 12.07 | 50,694.00 |
2023-10-26 | Kulkarni Sandeep Chidambar | director, officer: CEO | 725,735 | P-Purchase | A | 5,000 | 12.25 | 61,250.00 |
2023-10-24 | Kulkarni Sandeep Chidambar | director, officer: CEO | 720,735 | P-Purchase | A | 4,650 | 10.68 | 49,662.00 |
2023-10-24 | KANTOFF AARON | director | 45,391 | P-Purchase | A | 7,500 | 11.86 | 88,950.00 |
2023-10-25 | Thiara Parvinder | director | 82,782 | P-Purchase | A | 2,000 | 12.12 | 24,240.00 |
2023-10-24 | Thiara Parvinder | director | 80,782 | P-Purchase | A | 5,000 | 10.66 | 53,300.00 |
2023-10-19 | Thiara Parvinder | director | 75,782 | A-Award | A | 75,782 | 0.00 | 0.00 |
2023-10-23 | Thiara Parvinder | director | 10,000 | A-Award | A | 10,000 | 9.46 | 94,600.00 |
2023-10-23 | Srivastava Sapna | director | 20,000 | A-Award | A | 20,000 | 9.46 | 189,200.00 |
2023-10-19 | Srivastava Sapna | director | 518 | A-Award | A | 518 | 8,066.00 | 4,178,188.00 |
2023-10-19 | Srivastava Sapna | director | 0 | D-Return | D | 20,500 | 2.54 | 52,070.00 |
2023-10-19 | Robinson Ryan F. | officer: Interim CFO | 40,211 | A-Award | A | 40,211 | 13.92 | 559,737.00 |
2023-10-23 | Robinson Ryan F. | officer: Interim CFO | 16,000 | A-Award | A | 16,000 | 9.46 | 151,360.00 |
2023-10-19 | MIDDLEKAUFF W BRADFORD | officer: CBO, GC and Secretary | 124,991 | A-Award | A | 124,991 | 7.90 | 987,429.00 |
2023-10-19 | MIDDLEKAUFF W BRADFORD | officer: CBO, GC and Secretary | 69,201 | A-Award | A | 69,201 | 0.00 | 0.00 |
2023-10-23 | MIDDLEKAUFF W BRADFORD | officer: CBO, GC and Secretary | 46,774 | A-Award | A | 46,774 | 9.46 | 442,482.00 |
2023-10-19 | MCDADE MARK | director | 348,431 | A-Award | A | 348,431 | 0.00 | 0.00 |
2023-10-23 | MCDADE MARK | director | 20,000 | A-Award | A | 20,000 | 9.46 | 189,200.00 |
2023-10-19 | MCDADE MARK | director | 518 | A-Award | A | 518 | 8,066.00 | 4,178,188.00 |
2023-10-19 | MCDADE MARK | director | 0 | D-Return | D | 20,500 | 2.54 | 52,070.00 |
2023-10-19 | Kulkarni Sandeep Chidambar | director, officer: CEO | 716,085 | A-Award | A | 716,085 | 0.00 | 0.00 |
2023-10-19 | Kulkarni Sandeep Chidambar | director, officer: CEO | 528,794 | A-Award | A | 528,794 | 7.90 | 4,177,473.00 |
2023-10-23 | Kulkarni Sandeep Chidambar | director, officer: CEO | 254,207 | A-Award | A | 254,207 | 9.46 | 2,404,798.00 |
2023-10-19 | KANTOFF AARON | director | 37,891 | A-Award | A | 37,891 | 0.00 | 0.00 |
2023-10-19 | KANTOFF AARON | director | 37,890 | A-Award | A | 37,890 | 0.13 | 4,926.00 |
2023-10-23 | KANTOFF AARON | director | 10,000 | A-Award | A | 10,000 | 9.46 | 94,600.00 |
2023-10-19 | Jones Susan Dana | officer: Chief Technology Officer | 76,219 | A-Award | A | 76,219 | 7.90 | 602,130.00 |
2023-10-23 | Jones Susan Dana | officer: Chief Technology Officer | 46,774 | A-Award | A | 46,774 | 9.46 | 442,482.00 |
2023-10-19 | Jones Susan Dana | officer: Chief Technology Officer | 22,934 | A-Award | A | 22,934 | 0.00 | 0.00 |
2023-10-19 | Johnson Kevin Bruce | officer: Chief Regulatory Officer | 96,146 | A-Award | A | 96,146 | 7.90 | 759,553.00 |
2023-10-19 | Johnson Kevin Bruce | officer: Chief Regulatory Officer | 57,834 | A-Award | A | 57,834 | 0.00 | 0.00 |
2023-10-23 | Johnson Kevin Bruce | officer: Chief Regulatory Officer | 46,774 | A-Award | A | 46,774 | 9.46 | 442,482.00 |
2023-10-19 | CHYUNG YUNG H. | officer: Chief Medical Officer | 144,215 | A-Award | A | 144,215 | 7.90 | 1,139,298.00 |
2023-10-23 | CHYUNG YUNG H. | officer: Chief Medical Officer | 73,211 | A-Award | A | 73,211 | 9.46 | 692,576.00 |
2023-10-19 | CHYUNG YUNG H. | officer: Chief Medical Officer | 56,836 | A-Award | A | 56,836 | 0.00 | 0.00 |
2023-10-19 | Castelein Caley | director | 496,519 | A-Award | A | 496,519 | 0.00 | 0.00 |
2023-10-19 | Castelein Caley | director | 458,039 | A-Award | A | 458,039 | 0.00 | 0.00 |
2023-10-23 | Castelein Caley | director | 10,000 | A-Award | A | 10,000 | 9.46 | 94,600.00 |
2023-10-19 | Thiara Parvinder | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Robinson Ryan F. | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | MIDDLEKAUFF W BRADFORD | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Kulkarni Sandeep Chidambar | director, officer: CEO | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | KANTOFF AARON | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Jones Susan Dana | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Johnson Kevin Bruce | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | CHYUNG YUNG H. | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Chester Cariad | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-10-19 | Castelein Caley | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-07-03 | Fenton Mary Kay | officer: Chief Financial Officer | 68,054 | F-InKind | D | 12,946 | 3.08 | 39,874.00 |
2023-07-03 | Requadt Scott | 578,403 | F-InKind | D | 11,786 | 3.08 | 36,301.00 | |
2023-06-13 | Srivastava Sapna | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-13 | Smith Karen L. | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-13 | Shah Gaurav | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-13 | Nader Francois | director | 41,000 | A-Award | A | 41,000 | 2.54 | 104,140.00 |
2023-06-13 | MCDADE MARK | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-13 | MACKAY GEOFFREY | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-12 | Ildstad Suzanne | director | 3,798,542 | S-Sale | D | 16,870 | 2.59 | 43,725.00 |
2023-06-13 | Ildstad Suzanne | director | 3,784,334 | S-Sale | D | 14,208 | 2.56 | 36,338.00 |
2023-06-14 | Ildstad Suzanne | director | 3,771,392 | S-Sale | D | 12,942 | 2.49 | 32,244.00 |
2023-06-13 | Ildstad Suzanne | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-13 | Agarwala Sandip | director | 20,500 | A-Award | A | 20,500 | 2.54 | 52,070.00 |
2023-06-07 | Ildstad Suzanne | director | 3,881,473 | S-Sale | D | 75,001 | 2.39 | 179,095.00 |
2023-06-08 | Ildstad Suzanne | director | 3,840,831 | S-Sale | D | 40,642 | 2.48 | 100,772.00 |
2023-06-09 | Ildstad Suzanne | director | 3,815,412 | S-Sale | D | 25,419 | 2.46 | 62,637.00 |
2023-06-05 | Ildstad Suzanne | director | 2,782,023 | S-Sale | D | 7,841 | 2.52 | 19,755.00 |
2023-06-06 | Ildstad Suzanne | director | 2,756,474 | S-Sale | D | 25,549 | 2.53 | 64,596.00 |
2023-06-01 | Ildstad Suzanne | director | 2,805,682 | S-Sale | D | 15,713 | 2.56 | 40,177.00 |
2023-06-02 | Ildstad Suzanne | director | 2,789,864 | S-Sale | D | 15,818 | 2.50 | 39,616.00 |
2023-04-21 | Ildstad Suzanne | director | 2,821,395 | S-Sale | D | 15,004 | 2.35 | 35,231.00 |
2023-04-19 | Ildstad Suzanne | director | 2,883,389 | S-Sale | D | 21,753 | 2.16 | 47,056.00 |
2023-04-20 | Ildstad Suzanne | director | 2,836,399 | S-Sale | D | 46,990 | 2.33 | 109,313.00 |
2023-04-17 | Ildstad Suzanne | director | 2,954,353 | S-Sale | D | 99,771 | 2.14 | 213,530.00 |
2023-04-18 | Ildstad Suzanne | director | 2,905,142 | S-Sale | D | 49,211 | 2.15 | 105,804.00 |
2023-03-17 | Ildstad Suzanne | director | 3,054,124 | S-Sale | D | 10,436 | 2.06 | 21,543.00 |
2023-03-03 | Ildstad Suzanne | director | 3,064,560 | S-Sale | D | 6,806 | 2.06 | 13,992.00 |
2023-03-01 | Ildstad Suzanne | director | 3,071,366 | S-Sale | D | 29 | 2.05 | 59.45 |
2023-02-21 | Ildstad Suzanne | director | 3,071,395 | S-Sale | D | 3,500 | 2.05 | 7,185.00 |
2023-02-16 | Ildstad Suzanne | director | 3,078,507 | S-Sale | D | 2,939 | 2.06 | 6,040.00 |
2023-02-17 | Ildstad Suzanne | director | 3,074,895 | S-Sale | D | 3,612 | 2.05 | 7,406.00 |
2023-03-17 | Ildstad Suzanne | director | 3,054,124 | S-Sale | D | 10,436 | 2.06 | 21,543.00 |
2023-03-03 | Ildstad Suzanne | director | 3,064,560 | S-Sale | D | 6,806 | 2.06 | 13,992.00 |
2023-03-01 | Ildstad Suzanne | director | 3,071,366 | S-Sale | D | 29 | 2.05 | 59.45 |
2023-02-21 | Ildstad Suzanne | director | 3,071,395 | S-Sale | D | 3,500 | 2.05 | 7,185.00 |
2023-02-16 | Ildstad Suzanne | director | 3,078,507 | S-Sale | D | 2,939 | 2.06 | 6,040.00 |
2023-02-17 | Ildstad Suzanne | director | 3,074,895 | S-Sale | D | 3,612 | 2.05 | 7,406.00 |
2023-02-01 | Zdanowski Michael | officer: Chief Technology Officer | 150,000 | A-Award | A | 150,000 | 1.73 | 259,500.00 |
2023-02-01 | Zdanowski Michael | officer: Chief Technology Officer | 150,000 | A-Award | A | 150,000 | 1.73 | 259,500.00 |
2022-12-30 | Requadt Scott | director, officer: Chief Executive Officer | 590,193 | A-Award | A | 4 | 0.87 | 3.47 |
2023-02-01 | Requadt Scott | director, officer: Chief Executive Officer | 320,000 | A-Award | A | 320,000 | 1.73 | 553,600.00 |
2023-02-01 | Requadt Scott | director, officer: Chief Executive Officer | 320,000 | A-Award | A | 320,000 | 1.73 | 553,600.00 |
2023-02-01 | Krieger Nancy | officer: Chief Medical Officer | 120,000 | A-Award | A | 120,000 | 1.73 | 207,600.00 |
2023-02-01 | Krieger Nancy | officer: Chief Medical Officer | 120,000 | A-Award | A | 120,000 | 1.73 | 207,600.00 |
2023-02-01 | Fenton Mary Kay | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 1.73 | 259,500.00 |
2023-02-01 | Fenton Mary Kay | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 1.73 | 259,500.00 |
2022-09-10 | Zdanowski Michael | officer: Chief Technology Officer | 121,470 | A-Award | A | 120,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.